Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Oct 14.
Published in final edited form as: Med Phys. 2026 Oct;53(10):e70670. doi: 10.1002/mp.70670

Simultaneous T1, T2, R2*, PDFF, and Triglyceride Quantification in the Head and Neck Using Magnetic Resonance Fingerprinting on a 1.5T MR-Linac

Lucas McCullum 1,2, Ergys Subashi 3, Samuel L Mulder 1,2, Brian A Taylor 4, Ken-Pin Hwang 4, Clifton D Fuller 2, Jason Ostenson 5
PMCID: PMC13660436  NIHMSID: NIHMS2207091  PMID: 42852856

Abstract

Background

The extraction of quantitative biomarkers on the MR-Linac, which have been shown to be promising in the head and neck, remains a significant challenge due to the strict time constraints.

Purpose

The purpose of this study was to assess the technical feasibility of magnetic resonance fingerprinting (MRF) to simultaneously extract quantitative T1, T2, R2*, PDFF, and triglyceride composition in the head and neck on the MR-Linac.

Methods

Inversion-prepared, multi-echo, golden angle radial, variable flip angle, MRF data were acquired on a 1.5T MR-Linac. The data were corrected for phase errors in the bipolar multi-echo acquisition followed by low rank reconstruction with total variation regularization. A dictionary of signals parameterized by T1/T2 was calculated with an extended phase graph algorithm. The singular images were constructed using a signal subspace from the dictionary and the first singular images were then jointly fit for R2* and PDFF using the off-resonance information from an independent B0 map. The complete set of B0/T2*-corrected fat-water separated water singular images were fitted for T1/T2. Triglyceride composition was computed using the multi-echo complex readout. Three phantoms and three healthy volunteers were assessed for accuracy, repeatability, and reproducibility against validated reference sequences across five days using a test-retest setup.

Results

All coefficients of determination were at least 0.9 against reference sequences in standard phantoms across all quantitative parameters. The repeatability and reproducibility averaged under 5% in phantoms and under 10% in healthy volunteers.

Conclusion

The proposed MRF acquisition demonstrated the potential to replace the current time-intensive sequences on the 1.5T MR-Linac, thus increasing the adoption of specialized quantitative imaging biomarker approaches at high temporal density in the head and neck.

1. INTRODUCTION

On the MR-Linac, an integrated magnetic resonance imaging (MRI) and radiation therapy delivery linear accelerator (Linac) device1, head and neck cancer patients may receive daily MRI acquisitions for up to six weeks2 opening the door for robust normal tissue response modeling and imaging biomarker-based treatment adaptation3. Specifically, recent work has shown that changes in T1-weighted signal intensity4 and fat fraction in salivary glands following radiation-induced damage5,6. A recent study also demonstrated quantitative T1 and T2 changes in the gross tumor volume from pre- to mid- to post-radiation therapy7. Further work probing quantitative tissue T1, T2, apparent diffusion coefficient (ADC), and dynamic contrast enhanced (DCE) properties has recently been investigated for feasibility, demonstrating clinically significant levels of repeatability and reproducibility8,9. However, serial quantitative imaging suffers from prohibitively long scan times, resulting in limited sequences being available per treatment session due to time constraints for patient comfort and clinical throughput8,10,11. Further, acquiring quantitative maps serially will suffer from higher probability of misregistration error due to the potential for patient adjustments both intra- and inter-scan12. Therefore, simultaneous multiparametric quantitative MRI methods must be explored to fully take advantage of the limited time available on the MR-Linac.

Prior studies have evaluated the technical feasibility of the 2D multi-dynamic multi-echo (MDME; SyntheticMR AB; Linköping, Sweden) sequence for simultaneous quantification of T1, T2, and PD in a scan time under six minutes using the 1.5T MR-Linac13,14. Additionally, the multi-echo Dixon sequence (i.e., mDIXON-Quant on Philips systems) can provide quantitative B0, R2*, and PDFF maps from a single acquisition15. The resulting individual complex echo images can also be used to estimate the composition of triglycerides16. Magnetic resonance fingerprinting (MRF), on the other hand, is a recent innovation designed to simultaneously extract multiple quantitative property maps in a single, co-registered, acquisition17. Some examples18 are mapping T1 and T217, T1ρ19, B0 and B1+20, R2*21, cerebral blood volume22, diffusion23, perfusion24, and fat signal fraction25,26. However, on the MR-Linac, only four studies to the authors’ knowledge have evaluated the potential of MRF on the MR-Linac clinical workflow11,27–29 with only one focused on the 1.5T MR-Linac11 which only investigated T1, T2 and PD.

While promising, the integration of quantitative maps currently available clinically (i.e., MDME for T1, T2, and PD; mDIXON-Quant for B0, R2*, PDFF, and triglyceride composition) into a single acquisition remains unexplored on the 1.5T MR-Linac. Further, triglyceride composition estimation is not natively available from the clinical mDIXON-Quant sequence; it would have to either be estimated offline or through the Philips Research Imaging Development Environment (PRIDE). Even after this, the MDME and mDIXON-Quant images may not be aligned with the MRF acquisition at the voxel-level due to their different sequence optimization requirements, possible geometric distortion, and patient motion. Therefore, the purpose of this study is to investigate the technical feasibility of utilizing MRF on the 1.5T MR-Linac to simultaneously quantify T1, T2, R2*, PDFF, and the derived triglyceride composition in the head and neck region as a first-in-human R-IDEAL30 Stage 0/1 study. We will achieve this by (1) validating quantitative accuracy, repeatability, and reproducibility in phantoms, and (2) validating quantitative accuracy, repeatability, and reproducibility in healthy volunteers. The results of this study can be used to determine the threshold for true quantitative changes outside of acquisition variability using our proposed MRF technique in head and neck cancer patients treated on the 1.5T MR-Linac.

2. METHODS / MATERIALS

2.1. MRI Acquisition Parameters

All data were acquired using a 1.5T (Philips Healthcare; Best, The Netherlands) Elekta Unity MR-Linac (Elekta AB; Stockholm, Sweden) running software version R5.7.1.2 and using the 2 × 4-channel anterior/posterior coils in place of the available quadrature body coil (QBC). For reference, this MR-Linac has a maximum gradient strength of 15 mT/m and slew rate of 65 T/m/s.

The proposed 2D MRF sequence utilized a golden angle (~111°) full-spoke radial gradient echo acquisition, 100 ms inversion time pre-pulse, and a nine-echo bipolar readout. A total of 2048 dynamics were acquired where the flip angle was varied between 0° and 60° by a series of squared sine waves with pseudo-random varying amplitude while the TR was kept constant at 20 ms. A first-order volume shim31 was applied to optimize the B0 magnetic field homogeneity while a high time bandwidth product of 10 (“sg_500_200_0”; 5 sinc-periods, 2 Gauss deviations, no shift) was chosen for the RF pulse to avoid slice profile B1+ heterogeneity effects using a 2D approach32,33. A total of eight crusher gradient cycles were applied between each dynamic to ensure full residual magnetization dephasing to prevent signal contamination25,33,34. Additionally, an extended waiting time of 12 seconds was applied at the beginning of the sequence to ensure all magnetization had fully recovered and was known to be in equilibrium from any previous MRI scans.

To validate the proposed MRF quantification accuracy, we developed independent quantitative mapping sequences and validated their performance in phantoms with known reference values. For quantitative T1 and T2, the 2D multi-dynamic multi-echo (MDME; SyntheticMR AB; Linköping, Sweden) sequence was used as previously rigorously validated on the 1.5T MR-Linac13,14. The quantitative R2* and PDFF values were validated using the mDIXON-Quant6,35,36 technique which employs a multi-echo gradient echo sequence and multi-peak fat model with eddy current compensation post-processing in real-time on the scanner. Immediate calculated R2* and PDFF maps were available from the scanner in DICOM format37. A dual-echo independent B0 map was acquired for off-resonance corrections. The total scan time for all acquisitions was 4 minutes 22 seconds per repetition. Further acquisition details for both the proposed MRF acquisition and reference acquisitions can be seen in Table 1 and in Figure S-1, Figure S-2, and Figure S-3 in the Supplementary Materials.

Table 1.

The MRI acquisition parameters for the proposed MRF acquisition and its related validation sequences.

B0 Map mDIXON-Quant MDME MRF

Field of View (mm3) 256 x 256 x 10 256 x 256 x 30 256 x 256 x 45 256 x 256 x 10
Acquired Voxel Size (mm3) 1.5 x 1.5 x 10 2.4 x 2.4 x 10 2 x 2 x 3 1.5 x 1.5 x 10
Matrix Size 172 x 172 x 1 108 x 107 x 3 128 x 117 x 15 172 x 172 x 1
Reconstructed Voxel Size (mm3) 0.8 x 0.8 x 10 0.8 x 0.8 x 10 0.8 x 0.8 x 3 0.8 x 0.8 x 10
Flip Angle (°) 20 5 160 0 – 60 (variable)
TR (ms) 12 20 4000 20
TE (ms) 4.6 1.49 24 / 127 3.21
ΔTE (ms) 4.6 1.19 - 1.53
NTE 2 6 2 9
Bandwidth (Hz/Pixel) 734.1 / 0.296 1512.9 / 0.144 230.9 / 0.941 949.9 / 0.229
NSA 5 4 1 1
Additional Notes - - CS-SENSE = 2, TSE Factor = 12 Ndynamics = 2048, TI = 100 ms
Scan Time (m:ss) 0:21 0:24 2:44 0:53

Note that some parameters may not be applicable for the specified sequence which is indicated by a dashed line. Also note that the 12 second waiting time is included in the 53 second MRF acquisition time. Abbreviations: Ndynamics = number of dynamics, NSA = number of signal averages, TE = echo time, TI = inversion time, TR = repetition time, TSE = turbo spin echo.

2.2. Phantom / Human Subject Assessment

The CaliberMRI “NIST/ISMRM” Premium System Phantom Model 130 phantom (CaliberMRI; Boulder, CO, USA) was used as a reference for NIST-traceable T1 and T2 values38. The T2 vial layer was utilized to validate quantitative T1 and T2 parameter concordance due to their more clinically relevant T2 values. Another phantom was developed in-house for PDFF concordance using varying percentages of distilled water, vegetable oil (100% soybean oil), and a liquid lecithin emulsifier39,40. Nominal fat fractions of 0%, 25%, 50%, 75%, and 100% were created in 30 mm diameter / 50 mL vials (SimPure; Auburn, WA, USA) and partially submerged in distilled water for better signal characterization due to their smaller size. The vials were shaken immediately prior to scanning to ensure full fat / water mixing. Since the R2* did not have reported nominal values for the NIST/ISMRM phantom or our in-house phantom, we additionally scanned the Calimetrix Model 725 PDFF-R2* phantom41 (Calimetrix; Madison, WI, USA).

The bore temperature was monitored using a manual thermometer which regularly read near 20°C across all acquisitions for each scanner. Repeatability and reproducibility in the NIST/ISMRM phantom, Calimetrix phantom, and the in-house PDFF phantom was conducted by scanning them for a total of five days in a row using a test-retest methodology for each session. Specifically, the phantom was re-positioned following each scan, thus necessitating novel parameters for frequency adjustment, B0 shimming, B1+ calibration, and coil tuning. This was done separately for each phantom. The quantitative analysis was restricted to the following clinically-relevant ranges42: T1 = 250 – 1750 ms, T2 = 25 – 200 ms, PDFF = 0 – 100%, and R2* = 0 – 100 1/s.

In addition to phantom evaluation, a total of three healthy subjects were recruited and scanned using the imaging protocol in Table 1 in a test-retest style where they were asked to leave the bore and move around prior to re-positioning to trigger the new pre-scan parameters. All participants provided written informed consent to an internal volunteer imaging protocol (PA15–0418), both approved by the institutional review board at The University of Texas MD Anderson Cancer Center. The desired structures of interest in the head and neck that were assessed were the bilateral parotid glands (PG), bilateral masseter muscle (MM), bilateral medial pterygoid muscle (MPM), and bilateral middle superficial cheek fat (MSCF). Each structure was contoured for each timepoint and repetition using the individual gradient echo images from the B0 map by an experienced clinical professional in 3D Slicer43 (https://www.slicer.org).

2.3. MRF Dictionary Generation and Image Reconstruction

The MRF reconstruction was partially completed by a pre-computed dictionary which was generated using MATLAB R2023a (The MathWorks, Inc.; Natick, MA, USA) and is freely available at: https://github.com/Lucas-Mc/MRF-MRL. The flip angle train was read using comma-separated value (CSV) format and simulated into a signal evolution dictionary using the extended phase graph method44. The simulated T1 values ranged from 100 – 2000 ms with 75 log-spaced steps and the simulated T2 values ranged from 5 – 500 ms with 75 log-spaced steps. The total computational time for dictionary generation was 42 seconds while the remaining image generation was 20 minutes using a Dell Inc. Latitude 7320 operating Windows 10 Enterprise with an 11th Gen Intel Core i7–1185G7 processor with 4 cores and 16 GB of RAM. The wide range of T2 values was to accommodate the NIST/ISMRM phantom which includes large T2 values along with its large T1 value vials.

The first step in the MRF reconstruction was the processing of the raw image data which was saved directly from the scanner using Philips DATA/LIST format. Next, the inter-excitation basis for the T1/T2 dictionary was calculated from singular value decomposition45 using a rank factor of 0.9999 (i.e., components contributing to the highest 99.99% of the total energy were kept). This reduced number of components (~6) was used to generate a compressed dictionary for later signal matching. Each echo, and corresponding singular images, was reconstructed using the forward and adjoint Flatiron Institute nonuniform fast Fourier transform46,47 (NUFFT) operators at a precision of 10−10 with low-rank subspace dimensionality reduction48 from the previously determined number of significant components via a low-rank total variation49 (LRTV) reconstruction using 40 iterations, initial step size = 2−10, regularization weight = 5 × 10−3, and backtracking adaptive step size search. The coil sensitivity maps were then computed from the LRTV reconstruction using a matched filtering50 approach from the first singular image of the first echo and then applied to subsequent echoes to correct for inhomogeneous signal intensities.

To achieve estimated R2* and PDFF, the reconstructed first singular images of all echoes and the independent B0 images were processed through the PRESCO algorithm51 assuming 2.8 double bonds, non-negative R2* and PDFF, a maximum of 10 iterations for fat-water swap reduction, 8 iterations for the gradient descent, and 3 iterations for the line search. To estimate T1 and T2, the separated fat and water first singular image components were individually fit to the pre-computed and compressed dictionary using inner product matching52. Since our T1 and T2 estimates were separated into fat and water components, we utilized the bulk estimation (weighted sum of fat- and water-separated first singular images according to the fat signal fraction) to compare to our ground truth references since they were not fat nor water suppressed prior to image acquisition.

Then, to estimate the complex fat-water separated signal components, the reconstructed singular images of all echoes were first corrected for using the independent B0 and phase maps jointly with the R2* map from PRESCO and then separated using pre-defined 10-peak fat and water signal models53. Then, to compute the number of double bonds (ndb) and number of methylene interrupted double bonds (nmidb), the ratio between the signal from both the olefinic and diallylic peaks and the bulk methylene peak were determined using the signal evolution of the first singular image and a system of equations of the theoretical peak amplitudes to solve for ndb and nmidb from Peterson et al. 202154. Next, the chain length (CL) was computed from Bydder et al.16 and the fraction of saturated fatty acids (%SFA), monounsaturated fatty acids (%MUFA), and polyunsaturated fatty acids (%PUFA) from Peterson et al.54. The fraction of triunsaturated fatty acids (%TUFA) was assumed to be 0% and ignored due to its relatively low potential bias at 2% fixed across the entire volume55,56. The final triglyceride singular images were recombined using a weighted sum of all singular images. Soybean oil reference values for ndb and nmidb were derived from Peterson et al. 201357 and the %SFA, %MUFA, and %PUFA were derived from the United States Department of Agriculture Nutrient Database. An abbreviated visual methods overview of the methods is provided in Figure 1 and in Figure S-4 in the Supplementary Materials.

Figure 1.

Figure 1.

A high-level graphical overview of the MRF methodology used in this study: 1) image acquisition using a golden angle radial readout across multiple dynamics with variable flip angle and constant TR, 2) image reconstruction using a LRTV-based reconstruction followed by dictionary matching for T1/T2 and curve fitting for R2*/PDFF/triglyceride composition, 3) comparison to validated references, and 4) test-retest studies in phantoms and human subjects.

2.4. Statistical Analysis

All relevant analysis concerning statistical methods were formulated using the guidelines for reporting Statistical Analyses and Methods in the Published Literature (SAMPL)58. First, the concordance between the reference sequences and the phantom nominal values were compared using the squared Pearson correlation coefficient59, or the coefficient of determination (R2), for the T1, T2, R2*, and PDFF values. Next, a linear fit for the reference acquisitions against nominal phantom reference values was computed from solving a Vandermonde matrix60. For this computation, a y-intercept of 0 was chosen to assume that a quantitative reference value of 0 will lead to a direct matching to the proposed MRF values due to no detectable signal (T1, T2, R2*) and no confounding effects of fat (PDFF). The resulting first-order slopes were extracted and used to determine linear bias. After establishing the linear bias in the reference sequences, the proposed MRF sequence values against the reference sequence values were compared using the same strategy along with a Bland-Altman61 analysis. To validate the ndb, nmidb, CL, %SFA, %MUFA, and %PUFA, the 100% soybean oil vial was compared between all the repeated acquisitions and the known reference values57,62 and the United States Department of Agriculture Nutrient Database. The median and interquartile range (IQR) was used to assess its agreement to these reference values. The repeatability and reproducibility of both the proposed MRF sequence and the reference sequences were computed using the percentage of the standard deviation to the mean, or the coefficient of variation (CoV), both within the same subject for repeatability and between subjects for reproducibility.

3. RESULTS

The performance of MDME for T1 and T2 and mDIXON-Quant for R2* and PDFF across the five repeated days of test-retest in their respective reference phantoms are shown in Figure 2. The MDME sequence showed an R2 agreement of 0.99 for T1 and 0.99 for T2 while the slope for each linear fit was 1.08 and 0.87, respectively. Comparable results were seen using the mDIXON-Quant sequence with an R2 agreement of 0.94 for R2* and 0.99 for PDFF with slopes of 1.02 and 1.00, respectively.

Figure 2.

Figure 2.

Concordance plots of the quantitative T1 (top left), T2 (top right), R2* (bottom left), and PDFF (bottom right) values from the proposed ground-truth sequences (MDME for T1 and T2, mDIXON-Quant for R2* and PDFF) compared to the phantom nominal reference values (dashed black line, CaliberMRI NIST/ISMRM Model 130 for T1 and T2, Calimetrix Model 725 for PDFF and R2*, and in-house phantom for PDFF). For each series of data, a linear best-fit line (solid black line) was computed along with its 95% confidence intervals (dashed red lines).

After verification of the reference sequences, direct comparison between these sequences and the MRF values in the phantoms was performed, allowing for future comparison in human subjects. The results comparing MDME (T1 and T2) and mDIXON-Quant (R2* and PDFF) with MRF values across the five repeated days of test-retest are shown in Figure 3. The R2 agreements were 0.99, 0.94, 0.93, and 0.98 while the linear fit slopes were 0.98, 1.14, 1.28, and 1.08 for T1, T2, R2*, and PDFF, respectively. A direct comparison of the phantom images is shown in Figure S-5 while a Bland-Altman analysis of the proposed MRF values against the phantom references values is shown in Figure S-6 and Figure S-7, respectively, in the Supplementary Materials.

Figure 3.

Figure 3.

Concordance plots of the quantitative T1 (top left), T2 (top right), R2* (bottom left), and PDFF (bottom right) values from the proposed MRF sequence (black dots) compared to the reference sequences (dashed black line). For each series of data, a linear line of best fit (solid black line) was computed along with its 95% confidence intervals (dashed red lines).

For conciseness, the triglyceride composition results for both the phantom and healthy volunteers were combined in Figure 4. In the phantom, the ndb and nmidb were slightly underestimated while the remaining metrics were similar to soybean oil reference values. Quantitatively, the median [IQR] was 4.34 [3.98 – 4.47], 1.79 [1.53 – 1.89], 18.02 [17.91 – 18.05], 15.07 [14.32 – 18.37], 25.85 [23.16 – 31.22], and 59.74 [51.10 – 63.07] compared to reference values of 4.59, 2.07, 17.80, 15.75, 23.36, and 60.89 for ndb, nmidb, CL, %SFA, %MUFA, and %PUFA, respectively.

Figure 4.

Figure 4.

Repeatability of the triglyceride characterization in the 100% soybean oil vial from the in-house phantom (left) and the middle superficial cheek fat (right) compared to reference values (dashed black line). Note, the difference in the reference values between soybean oil and human subcutaneous adipose tissue.

In the middle superficial cheek fat in healthy volunteers, the ndb and CL were slightly overestimated while the remaining metrics were similar to reference values for subcutaneous adipose tissue. Quantitatively, the median [IQR] was 2.97 [2.95 – 3.15], 0.91 [0.87 – 1.07], 17.63 [17.62 – 17.68], 33.63 [31.11 – 53.72], 30.55 [25.53 – 36.83], and 30.37 [28.99 – 35.62] compared to reference values of 2.72, 0.94, 17.30, 41.00, 28.00, and 31.00 for ndb, nmidb, CL, %SFA, %MUFA, and %PUFA, respectively.

Since MRF acquisitions were performed across five repeated days in a test-retest format for each day, the CoV could be characterized for both repeatability and reproducibility and is shown in Figure 5. All CoV were within 10% except for the reproducibility of the lowest R2* values which were ~11%. The lowest CoV was seen in the T1 values >1000 ms, T2 values >75 ms, R2* values >20 1/s except for ~50 1/s, and PDFF values of 50% and 100%.

Figure 5.

Figure 5.

Repeatability and reproducibility plots of the quantitative T1 (top left), T2 (top right), R2* (bottom left), and PDFF (bottom right) values from the proposed MRF sequence compared to the nominal values (NIST/ISMRM phantom reference values for T1/T2 and Calimetrix phantom for R2*/PDFF) or reference sequences (mDIXON-Quant for R2*). Note, the repeatability and reproducibility of 0% for PDFF levels of 0% and 100% due to zero variance in these measurements.

A representative compilation of the quantitative maps in a healthy volunteer generated from the proposed MRF sequence including T1 (fat / water / bulk), T2 (fat / water / bulk), R2*, PDFF, ndb, nmidb, CL, %SFA, %MUFA, and %PUFA is shown in Figure 6.

Figure 6.

Figure 6.

A visual summary of all the quantitative maps acquired in a single acquisition using the proposed MRF sequence in a healthy volunteer with a permanent retainer resulting in an anterior signal void. (1) Dictionary matching is utilized to fit for T1 and T2 which can then be separated into both fat and water components. (2) Curve fitting of the gradient echo signal decay can extract both the decay rate, R2*, and percent fat fraction, PDFF. (3) Further fitting of the complex gradient echo signal decay to various fat spectral peaks can lead to extraction of the ndb, nmidb, CL, %SFA, %MUFA, and %PUFA. Note, a fat mask (MRF PDFF > 90%) is used for the triglyceride characterization maps due to their unreliability in regions with minimal fat content.

A comparison of the quantitative values in each of the contoured structures across both test-retest scans in the three healthy volunteers for the proposed MRF acquisition against the reference acquisitions is shown in Figure 7. The T1 values showed the best agreement with an R2 of 0.84 and slope of 1.05 while the T2 values were slightly overestimated, though consistent, with an R2 of 0.76 and slope of 1.16 compared to the reference MDME acquisition. The R2* values showed the lowest agreement with an R2 of 0.47 and slope of 0.80, likely due to the drop in accuracy at the higher R2* values (>50 1/s). Finally, the PDFF values were the most consistent with an R2 of 0.98 and slope of 1.22.

Figure 7.

Figure 7.

A comparison between the proposed MRF acquisition and the reference acquisition (MDME for T1 / T2 and mDIXON-Quant for R2* / PDFF) across the two test-retest scans in the three healthy volunteers.

The quantitative repeatability and reproducibility results for Figure 7 are shown in Figure 8 with the addition of the triglyceride composition analysis. A lower CoV was seen in the MRF acquisition compared to MDME for both muscles in the quantitative T1 values. However, the CoV for the MRF acquisition was higher than MDME in the quantitative T2 measurements. In most of the R2* measurements, the CoV in the MRF acquisition was lower compared to mDIXON-Quant, while being comparable for the PDFF measurements. The CoV for the repeatability and reproducibility was the lowest in the CL while higher in the nmidb with most values ranging between 10% and 30%.

Figure 8.

Figure 8.

The repeatability in human subjects across the proposed MRF sequence and reference sequence for comparison for T1 (top left), T2 (top middle), R2* (bottom left), and PDFF (bottom middle) across all contoured structures. Also shown is the repeatability and reproducibility for ndb, nmidb, CL, %SFA, %MUFA, and %PUFA for the proposed MRF sequence (bottom right) for just the middle superficial cheek fat due to its high fat content. Abbreviations: rep = repeatability, repr = reproducibility, PG = parotid gland, MM = masseter muscle, MPM = medial pterygoid muscle, MSCF = middle superficial cheek fat.

4. Discussion

4.1. Summary

This work investigated the technical feasibility of simultaneously quantifying T1, T2, R2*, PDFF, triglyceride composition estimation (ndb, nmidb, CL, %SFA, %MUFA, and %PUFA) using MRF on a 1.5T MR-Linac. This study includes several novel contributions to the field of image-guided radiation therapy on a 1.5T MR-Linac, specifically: (1) the first published implementation of MRF on the 1.5T MR-Linac including R2*, PDFF, and triglyceride composition, (2) the first published implementation of MRF to include structures in the head and neck, and (3) the first published evaluation of the performance of mDIXON-Quant on the 1.5T MR-Linac.

We found that our proposed MRF sequence generated quantitative T113,63 and PDFF64–66 values that agreed with published reference values, R2*67 was underestimated in the parotid glands, and quantitative T113, T213, and PDFF66 were in agreement with published reference values in the muscles. Similar to the parotid, in the fat tissue, the quantitative T113 and PDFF65,66 agreed with published reference values while T213 was slightly overestimated. Exact quantitative R2* measurements in the muscles and fat of the head and neck could not be found in existing literature. An interesting finding was that the mDIXON-Quant appeared to underestimate the PDFF in the middle superficial cheek fat which needs to be investigated further. This could be because mDIXON-Quant uses a 7-peak fat model while our proposed method uses a 10-peak model by adding the glycerol head peaks, however their concentration is minimal. The mDIXON-Quant scan was also optimized for the liver and may not perform as well in more inhomogeneous regions such as the head and neck. For the triglyceride composition estimation, the IQR was within the expected reference values in the phantom except for the ndb and nmidb which were slightly underestimated and CL which was slightly overestimated. In the healthy volunteers, the ndb and CL were slightly overestimated.

4.2. Limitations

Several acquisition and reconstruction factors can potentially limit the precision of the quantitative measurements from MRF including patient motion, low signal-to-noise ratio (SNR) due to scan time constraints, or non-robust reconstruction pipelines. On the acquisition side, radial off-resonance effects cause phase inconsistencies across the radial spokes, especially near the end of the spoke with high frequency information, which can cause blurring, streaks, or rings68,69. However, our MRF acquisition utilized a high bandwidth per pixel which should minimize these concerns with the tradeoff of lower SNR. The first MRF implementation utilized spiral sampling17, and although spiral sampling provides a higher sampling efficiency, it does not sample the center of k-space as rapidly and is therefore more susceptible to motion compared to radial70. Second, spiral trajectories are more susceptible to off-resonance blurring and distortion than radial trajectories, a problem that becomes more pronounced in the head and neck with several air-tissue interfaces71. Third, spiral trajectories have more demanding gradient constraints which must constantly change to maintain a spiral shape, especially at high sampling density. These issues lead to increased reconstruction complexity due to the increased need for accurate off-resonance corrections.

Limiting our MRF dictionary to a maximum T1 and T2 of 2000 ms, may lead to an underestimation of free-water-dominant materials such as the cerebrospinal fluid (CSF)72. Similarly, tissues with short T2 times such as bone and tendons may experience a similar effect but as an overestimation72. Our dictionary range and spacing were chosen with computational memory constraints in mind so more investigation should be done by increasing the range and number of intervals with larger amounts of computational memory. However, the current study still covers a vast majority of the tissues represented in the head and neck region.

From the quantitative parameter validation perspective, there are several steps which can be taken to ensure more robustness. First, the Calimetrix phantom used in this study only contained R2* values near 50 1/s in our selected clinical range of 0 – 100 1/s which limits the validation of mDIXON-Quant compared to nominal values. The dedicated 12-vial R2* phantom from Calimetrix includes values of 15, 25, 50, 75, and 100 1/s which would provide a better characterization of our clinical range and should, therefore, be investigated further. Second, we noticed an overestimation of the proposed MRF sequence’s PDFF compared to that from mDIXON-Quant at a fat fraction of 50%. This could possibly be from the maximal interference from the water and fat signals, particularly occurring in cases of large phase errors73 or biased T2* corrections74. This could potentially be corrected for in future studies by applying advanced reconstruction techniques such as dual T2* correction74 or an independent T2* mapping technique outside of the one computed with mDIXON-Quant. Third, due to our low sensitivity for unconstrained estimates of nmidb, we decided to utilize the formulation from Peterson et al.54, resulting in derived values for CL, %SFA, %MUFA, and %PUFA that were dependent on the accuracy of the ndb measurement.

4.3. Future Work

For quantitative T1 and T2, an interleaved spin echo and inversion recovery sequence, or MIX75 acquisition on Philips devices, may yield a more accurate estimation at the price of a longer scan time compared to MDME and should be investigated further. Although not investigated here, the use of fat or water spectrally selective inversion pulses76–78 could have been employed for the quantitative T1 and T2 mapping techniques to validate the water- and fat-separated quantitative T1 and T2 values. For simultaneous R2* and PDFF estimation, the PRESCO algorithm was chosen, however further reconstruction methods should be investigated to validate its measured biases compared to mDIXON-Quant beyond the differences in first echo time and echo spacing79. Additionally, the use of an independent B0 map could be removed and replaced with the one estimated by PRESCO given it has acceptable level of bias. This may be improved by using higher-order shimming when available compared to just first-order as used in this study80. This would also prevent the possibility of mis-registration between the independent B0 map and the acquired MRF data, especially without image registration which would lead to fitting errors for the signal decay and subsequent R2* and PDFF maps in the case of motion81.

Another area of exploration is the overestimation in the R2* values from the proposed MRF method against mDIXON-Quant in phantoms, which could be due to the relatively large first echo time of 3.21 ms and larger echo spacing of 1.53 ms which fails to accurately capture the signal decay with sufficient SNR82. However, the overestimation is consistent with a high R2 and mean repeatability and reproducibility under 5% across all vials in the clinical reference range. After further investigation, the first echo time can be reduced to a minimum of 1.8 ms on the Elekta Unity MR-Linac if a hard block pulse shape is used, however, for 2D imaging, a higher time-bandwidth product pulse is desired to prevent signal cross talk and slice-profile effects that bias relaxometry estimates.

In some cases, the CoV was large especially when the mean approached 0% such as the PDFF in muscles. Larger healthy volunteer cohorts should be studied to determine if this will reduce the CoV, especially for the reproducibility quantification. Future work can also incorporate the fitted quantitative T2 values from MRF along with the derived T2* values from PRESCO to study the T2’ values and their potential as a longitudinal biomarker83. An improvement to the quantitative T2 mapping could be made with a T2-preparation module84. A random sample consensus (RANSAC) model85 could be used to generate a better lines of best fit which are more robust to outliers and non-linear trends, especially in the R2* fit in health volunteers which noted an increasingly negative bias at higher values. In individuals with lower amounts of subcutaneous adipose tissue, it was difficult to accurately estimate the triglyceride compositions due to signal influences from surrounding tissue boundaries. Therefore, a larger cohort of health volunteers should be studied further. Looking forward, we employed 2048 dynamics which led to a single slice scan time of just under one minute. Reducing this number could lead to a faster scan time at the expense of SNR, especially if the current spatial resolution and flip angle train are kept. Furthermore, substantial work on Cramér-Rao lower bound optimization has shown promise for alternative optimal flip angle trains that can significantly reduce the required number of dynamics for the desired quantitative accuracy86. Recent work has expanded this further to mitigate the inherent undersampling artifacts from MRF87, even extending this to quantitative fat fraction determination88. With strategic tradeoffs, expansion of this proposed MRF technique to single-slice abdominal applications within a single breath-hold should be achievable89. However, the abdomen presents with an increased concern for B1+ inhomogeneity artifacts which should be robustly handled in future translations of this work.

Of interest clinically would be extending this multi-slice 2D approach to a 3D approach which has been proposed by several authors previously90,91. This would significantly increase the scan time in order to maintain the current resolution unless substantial undersampling with advanced reconstruction, such as deep learning92, is utilized. This increased time can lead to enhanced artifacts from motion if substantial and left uncorrected. These concerns would have to be addressed to reduce the current slice thickness from 10 mm to more clinically realistic values of less than 5 mm. It is currently unclear how much acceleration is possible on the 1.5T MR-Linac due to its reduced gradient strength and slew rate compared to the diagnostic scanners where 3D MRF techniques have been implemented. Additionally, the reduced coil availability (4 linear channels anterior / 4 linear channels posterior) enhances this difficulty since coil-based acceleration techniques can only be in one direction. Further, the current reconstruction time of 20 minutes is slightly too long to be useful for most online MR-Linac treatments, but this can be improved with emerging deep learning based methods. However, these problems should be investigated further to enhance the information available during radiation therapy treatment planning adaptation at high resolution.

4.4. Significance

Beyond the head and neck, triglyceride composition estimation has previously been investigated in the breast93–95, liver96–98, cardiac tissue99–101, knee102, thigh103, and bone marrow104. In particular, applying this methodology to the bone marrow to separate yellow from red bone marrow105 can potentially be applied for red bone marrow sparing to minimize dose to radiosensitive lymphocytes106,107, thus reducing the risk of lymphopenia108,109. Additionally, data from over 33,000 patients in the UK Biobank110 has shown significant promise for the incorporation of triglyceride composition estimation to aid in risk stratification across genders and diets111. Recent work has taken this further by investigating ω−3 fatty acid mapping112 which is critical in inflammatory pathways113 and may be translated to future longitudinal radiation therapy studies114,115. One interesting study showed that radiation therapy in myxoid liposarcomas resulted in a reduced ndb in the tumor in patients with good response116 indicating the possibility of effective double bond breakage from the radiation117. A corroborative mouse study indicated changes in SFA and PUFA in response to radiation therapy118.

A promising application of this theory is visualizing the MRI-visible lipids in the tumor microenvironment119,120 in an attempt to peer into long-standing knowledge about the import role of lipids in cancer121. One study showed this through the substantial increase in PUFA seen following radiation therapy in a xenograft model of non-Hodgkin’s diffuse large B cell lymphoma, theorized to signal radiation therapy-induced apoptosis122,123. This correlation has also been seen in glioma in response to necrosis124,125 while also being seen in response to gene therapy126 and chemotherapy127. In addition, the PDFF values have been demonstrated as a biomarker for bone marrow cellularity128 which can be applied to assess bone metastases and osteoradionecrosis129. With the clinical applications of the MR-Linac expanding rapidly, applying the proposed MRF sequence in this study has the potential to generate novel insights into how tumors respond to radiation therapy at a high temporal density.

Simultaneous quantification of multiple MRI parameters in the same sequence is valuable on the MR-Linac where time constraints are necessary to minimize time the patient is on the table due to the combined imaging and radiation therapy delivery. Future applications of this work include: (1) expanding the proposed MRF sequence to other anatomical areas such as the prostate to longitudinally assess T1 and T2 changes130, (2) exploring the applications of quantitative R2* mapping for tracking hypoxia status131, and (3) investigating the changes in PDFF, and potentially the triglyceride composition, throughout the course of radiation therapy on the MR-Linac132–135. In summary, this work establishes a foundation for multiparametric MRF on the 1.5T MR-Linac, offering a pathway toward real-time, quantitative monitoring of treatment response in the head and neck.

Supplementary Material

Figure S1

Figure S-1. The first 500 ms of the sequence showing the inversion pulse and increasing flip angle amplitude in the RF amplitude line. Not shown is a manual delay of 12 seconds that was added before the inversion pulse to ensure equilibrium conditions are met following the prescan procedures.

Figure S4

Figure S-4. A visualization of the complete image acquisition to reconstruction workflow where green = input data, blue = data processing steps, yellow = decision step, orange = intermediate data, and red = final output data.

Figure S5

Figure S-5. A comparison of the quantitative T1, T2, R2*, and PDFF maps generated from the proposed MRF sequence (top) with the MDME for T1 / T2 and mDIXON-Quant for R2* / PDFF reference sequences for the same healthy volunteer at the same window / level settings.

Figure S2

Figure S-2. A single repetition of the bipolar gradient echo radial readout. Shown is the RF pulse centered on the slice-select gradient followed by a rephasing gradient before the start of the readout. Immediately following this, a dephasing gradient is played out in the frequency encoding direction followed by 9 bipolar gradient echo readouts without ramp sampling as seen in the acquisition line. Another gradient is utilized at the end of the bipolar gradient readout to return to the center of k-space while an 8-cycle gradient crusher is applied in the slice-select line.

Figure S3

Figure S-3. A sample flip angle train that was generated for the acquisitions in this study. Note that only the first 2048 dynamics were used.

Figure S6

Figure S-6. Concordance plots of the quantitative T1 (top left), T2 (top right), R2* (bottom left), and PDFF (bottom right) values from the proposed MRF sequence compared to the phantom nominal reference values (dashed black line, CaliberMRI NIST/ISMRM Model 130 for T1 and T2, Calimetrix Model 725 for R2* and PDFF, and additional in-house phantom for PDFF). For each series of data, a linear line of best fit (solid black line) was computed along with its 95% confidence intervals (dashed red lines).

Figure S7

Figure S-7. Bland-Altman plots of the quantitative T1 (top left), T2 (top right), R2* (bottom left), and PDFF (bottom right) values from the proposed MRF sequence compared to the reference values (CaliberMRI NIST/ISMRM Model 130 and MDME for T1 and T2, Calimetrix Model 725 and mDIXON-Quant for R2* and PDFF with additional in-house phantom for PDFF). For each series of data, the mean (solid line) was computed along with its 95% limits of agreement (dashed lines).

Acknowledgments

Notes: This manuscript is the result of funding in whole or in part by the National Institutes of Health (NIH). It is subject to the NIH Public Access Policy. Through acceptance of this federal funding, NIH has been given a right to make this manuscript publicly available in PubMed Central upon the Official Date of Publication, as defined by NIH.

Footnotes

Conflicts of Interest Statement: LM has received unrelated travel / hotel accommodations from Elekta AB. KH has received unrelated investigational software / research support from SyntheticMR AB and unrelated research support from GE Healthcare. CDF has received unrelated grant support from Elekta AB and holds unrelated patents licensed to Kallisio, Inc. (US PTO 11730561) through the University of Texas, from which they receive patent royalties. CDF has also received unrelated travel and honoraria from Elekta AB, Philips Medical Systems, Siemens Healthineers/Varian, and Corewell Health. Additionally, CDF has served in an unpaid advisory capacity for Siemens Healthineers/Varian and has served on the guidelines/scientific committee for Osteoradionecrosis for the American Society of Clinical Oncology.

Contributor Roles Taxonomy (CRediT) Attribution Statement: Conceptualization: L.M. and J.O.; Data curation: L.M. and J.O.; Formal analysis: L.M. and J.O.; Funding acquisition: C.D.F.; Investigation: L.M. and J.O.; Methodology: L.M. and J.O.; Project administration: J.O.; Resources: L.M., E.S., S.L.M., B.A.T., K.H., and J.O.; Software: L.M. and J.O.; Supervision: C.D.F. and J.O.; Validation: L.M. and J.O.; Visualization: L.M. and J.O.; Writing – original draft: L.M. and J.O.; Writing - review & editing: L.M., E.S., S.L.M., B.A.T., K.H., C.D.F., and J.O.;

Data Availability Statement:

All relevant anonymized imaging data necessary for figure reproduction is available at the following FigShare DOI: 10.6084/m9.figshare.30779273. The MRF reconstruction code is freely available at: https://github.com/Lucas-Mc/MRF-MRL.

References

  • 1.Winkel D, Bol GH, Kroon PS, et al. Adaptive radiotherapy: The Elekta Unity MR-linac concept. Clinical and Translational Radiation Oncology. 2019;18:54–59. doi: 10.1016/j.ctro.2019.04.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ocanto A, Torres L, Montijano M, et al. MR-LINAC, a New Partner in Radiation Oncology: Current Landscape. Cancers. 2024;16(2):2. doi: 10.3390/cancers16020270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Van Houdt PJ, Saeed H, Thorwarth D, et al. Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group. European Journal of Cancer. 2021;153:64–71. doi: 10.1016/j.ejca.2021.04.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.van Dijk LV, Thor M, Steenbakkers RJHM, et al. Parotid gland fat related Magnetic Resonance image biomarkers improve prediction of late radiation-induced xerostomia. Radiother Oncol. 2018;128(3):459–466. doi: 10.1016/j.radonc.2018.06.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhou N, Chu C, Dou X, et al. Early evaluation of radiation-induced parotid damage in patients with nasopharyngeal carcinoma by T2 mapping and mDIXON Quant imaging: initial findings. Radiation Oncology. 2018;13(1):22. doi: 10.1186/s13014-018-0970-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kise Y, Chikui T, Yamashita Y, Kobayashi K, Yoshiura K. Clinical usefulness of the mDIXON Quant the method for estimation of the salivary gland fat fraction: comparison with MR spectroscopy. The British Journal of Radiology. 2017;90(1077):20160704. doi: 10.1259/bjr.20160704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Bonate R, Awan M, Himburg H, et al. Patterns of response in head and neck cancer subregions using daily Quantitative MRI from MR-guided radiation therapy. Clinical and Translational Radiation Oncology. 2026;56:101059. doi: 10.1016/j.ctro.2025.101059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kooreman ES, Van Houdt PJ, Nowee ME, et al. Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator. Radiotherapy and Oncology. 2019;133:156–162. doi: 10.1016/j.radonc.2019.01.011 [DOI] [PubMed] [Google Scholar]
  • 9.Guerreiro F, Van Houdt P, Navest R, et al. Validation of quantitative magnetic resonance imaging techniques in head and neck healthy structures involved in the salivary and swallowing function: Accuracy and repeatability. Physics and Imaging in Radiation Oncology. 2024;31:100608. doi: 10.1016/j.phro.2024.100608 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Subashi E, LoCastro E, Apte A, Zelefsky MJ, Tyagi N. Quantitative Relaxometry for Target Localization and Response Assessment in Ultra-Hypofractionated MR-Guided Radiotherapy to the Prostate and DIL. International Journal of Radiation Oncology*Biology*Physics. 2022;114(3):S33. doi: 10.1016/j.ijrobp.2022.07.390 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bruijnen T, Van Der Heide O, Intven MPW, et al. Technical feasibility of magnetic resonance fingerprinting on a 1.5T MRI-linac. Phys Med Biol. 2020;65(22):22NT01. doi: 10.1088/1361-6560/abbb9d [DOI] [PubMed] [Google Scholar]
  • 12.Fast MF, Cao M, Parikh P, Sonke JJ. Intrafraction Motion Management With MR-Guided Radiation Therapy. Seminars in Radiation Oncology. 2024;34(1):92–106. doi: 10.1016/j.semradonc.2023.10.008 [DOI] [PubMed] [Google Scholar]
  • 13.McCullum L, Mulder SL, West NA, et al. Technical development and In Silico implementation of SyntheticMR in head and neck adaptive radiation therapy: A prospective R-IDEAL stage 0/1 technology development report. J Applied Clin Med Phys. 2025;26(7). doi: 10.1002/acm2.70134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.McCullum L, Mulder SL, West NA, et al. Technical Optimization of SyntheticMR for the Head and Neck on a 3T MR-Simulator and 1.5T MR-Linac: A Prospective R-IDEAL Stage 2a Technology Innovation Report. Preprint posted online April 10, 2025. doi: 10.1101/2025.04.08.25325491 [DOI] [Google Scholar]
  • 15.Kise Y, Chikui T, Yamashita Y, Kobayashi K, Yoshiura K. Clinical usefulness of the mDIXON Quant the method for estimation of the salivary gland fat fraction: comparison with MR spectroscopy. The British Journal of Radiology. 2017;90(1077):20160704. doi: 10.1259/bjr.20160704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Bydder M, Girard O, Hamilton G. Mapping the double bonds in triglycerides. Magnetic Resonance Imaging. 2011;29(8):1041–1046. doi: 10.1016/j.mri.2011.07.004 [DOI] [PubMed] [Google Scholar]
  • 17.Ma D, Gulani V, Seiberlich N, et al. Magnetic resonance fingerprinting. Nature. 2013;495(7440):187–192. doi: 10.1038/nature11971 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chen Y, Lu L, Zhu T, Ma D. Technical overview of magnetic resonance fingerprinting and its applications in radiation therapy. Med Phys. 2022;49(4):2846–2860. doi: 10.1002/mp.15254 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wyatt CR, Barbara TM, Guimaraes AR. T1ρ Magnetic Resonance Fingerprinting. NMR in biomedicine. 2020;33(5):e4284. doi: 10.1002/nbm.4284 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Körzdörfer G, Jiang Y, Speier P, et al. Magnetic resonance field fingerprinting. Magnetic Resonance in Medicine. 2019;81(4):2347–2359. doi: 10.1002/mrm.27558 [DOI] [PubMed] [Google Scholar]
  • 21.Rieger B, Zimmer F, Zapp J, Weingärtner S, Schad LR. Magnetic resonance fingerprinting using echo-planar imaging: Joint quantification of T1 and relaxation times. Magnetic Resonance in Medicine. 2017;78(5):1724–1733. doi: 10.1002/mrm.26561 [DOI] [PubMed] [Google Scholar]
  • 22.Christen T, Pannetier NA, Ni WW, et al. MR vascular fingerprinting: A new approach to compute cerebral blood volume, mean vessel radius, and oxygenation maps in the human brain. NeuroImage. 2014;89:262–270. doi: 10.1016/j.neuroimage.2013.11.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Afzali M, Mueller L, Sakaie K, et al. MR Fingerprinting with b-Tensor Encoding for Simultaneous Quantification of Relaxation and Diffusion in a Single Scan. Magnetic Resonance in Med. 2022;88(5):2043–2057. doi: 10.1002/mrm.29352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fan H, Bunker L, Wang Z, et al. Simultaneous perfusion, diffusion, T*, and T mapping with MR fingerprinting. Magnetic Resonance in Medicine. 2024;91(2):558–569. doi: 10.1002/mrm.29880 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ostenson J, Damon BM, Welch EB. MR fingerprinting with simultaneous T1, T2, and fat signal fraction estimation with integrated B0 correction reduces bias in water T1 and T2 estimates. Magnetic Resonance Imaging. 2019;60:7–19. doi: 10.1016/j.mri.2019.03.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ostenson J, Robison RK, Brittain EL, Damon BM. Feasibility of joint mapping of triglyceride saturation and water longitudinal relaxation in a single breath hold applied to high fat-fraction adipose depots in the periclavicular anatomy. Magn Reson Imaging. 2023;99:58–66. doi: 10.1016/j.mri.2023.02.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nejad-Davarani SP, Zakariaei N, Chen Y, et al. Rapid multicontrast brain imaging on a 0.35T MR-linac. Med Phys. 2020;47(9):4064–4076. doi: 10.1002/mp.14251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mickevicius NJ, Kim JP, Zhao J, Morris ZS, Hurst NJ, Glide-Hurst CK. Toward magnetic resonance fingerprinting for low-field MR-guided radiation therapy. Med Phys. 2021;48(11):6930–6940. doi: 10.1002/mp.15202 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mickevicius NJ, Glide-Hurst CK. Low-rank inversion reconstruction for through-plane accelerated radial MR fingerprinting applied to relaxometry at 0.35 T. Magnetic Resonance in Medicine. 2022;88(2):840–848. doi: 10.1002/mrm.29244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Verkooijen HM, Kerkmeijer LGW, Fuller CD, et al. R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology. Front Oncol. 2017;7. doi: 10.3389/fonc.2017.00059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Schneider E, Glover G. Rapid in vivo proton shimming. Magnetic Resonance in Med. 1991;18(2):335–347. doi: 10.1002/mrm.1910180208 [DOI] [PubMed] [Google Scholar]
  • 32.Ma D, Coppo S, Chen Y, et al. Slice Profile and B1 Corrections in 2D Magnetic Resonance Fingerprinting (MRF). Magn Reson Med. 2017;78(5):1781–1789. doi: 10.1002/mrm.26580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Ostenson J, Smith DS, Does MD, Damon BM. Slice-selective extended phase graphs in gradient-crushed, transient-state free precession sequences: An application to MR fingerprinting. Magnetic Resonance in Med. 2020;84(6):3409–3422. doi: 10.1002/mrm.28381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Guenthner C, Amthor T, Doneva M, Kozerke S. A unifying view on extended phase graphs and Bloch simulations for quantitative MRI. Sci Rep. 2021;11(1):21289. doi: 10.1038/s41598-021-00233-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.McCullum L, West NA, Shin K, et al. Quantitative Dixon-Based PDFF and R2* Estimation and Optimization on MR-Simulation and MR-Linac Devices for the Pelvis and Head and Neck: A Prospective R-IDEAL Stage 0–2a Study. Radiology and Imaging. Preprint posted online March 10, 2026. doi: 10.64898/2026.03.09.26347965 [DOI] [Google Scholar]
  • 36.Kukuk GM, Hittatiya K, Sprinkart AM, et al. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol. 2015;25(10):2869–2879. doi: 10.1007/s00330-015-3703-6 [DOI] [PubMed] [Google Scholar]
  • 37.Bidgood WD, Horii SC, Prior FW, Van Syckle DE. Understanding and Using DICOM, the Data Interchange Standard for Biomedical Imaging. J Am Med Inform Assoc. 1997;4(3):199–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Carr ME, Keenan KE, Rai R, Metcalfe P, Walker A, Holloway L. Determining the longitudinal accuracy and reproducibility of T 1 and T 2 in a 3T MRI scanner. J Applied Clin Med Phys. 2021;22(11):143–150. doi: 10.1002/acm2.13432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ohmae E, Yoshizawa N, Yoshimoto K, et al. Stable tissue-simulating phantoms with various water and lipid contents for diffuse optical spectroscopy. Biomed Opt Express. 2018;9(11):5792. doi: 10.1364/BOE.9.005792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Yang JZ, Murphy R, Lu J. A fat fraction phantom for establishing new convolutional neural network to determine the pancreatic fat deposition. Heliyon. 2022;8(12):e12478. doi: 10.1016/j.heliyon.2022.e12478 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Zhao R, Hamilton G, Brittain JH, Reeder SB, Hernando D. Design and evaluation of quantitative MRI phantoms to mimic the simultaneous presence of fat, iron, and fibrosis in the liver. Magnetic Resonance in Med. 2021;85(2):734–747. doi: 10.1002/mrm.28452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Bojorquez JZ, Bricq S, Acquitter C, Brunotte F, Walker PM, Lalande A. What are normal relaxation times of tissues at 3 T? Magnetic Resonance Imaging. 2017;35:69–80. doi: 10.1016/j.mri.2016.08.021 [DOI] [PubMed] [Google Scholar]
  • 43.Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magnetic Resonance Imaging. 2012;30(9):1323–1341. doi: 10.1016/j.mri.2012.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Weigel M Extended phase graphs: dephasing, RF pulses, and echoes - pure and simple. J Magn Reson Imaging. 2015;41(2):266–295. doi: 10.1002/jmri.24619 [DOI] [PubMed] [Google Scholar]
  • 45.McGivney DF, Pierre E, Ma D, et al. SVD Compression for Magnetic Resonance Fingerprinting in the Time Domain. IEEE Trans Med Imaging. 2014;33(12):2311–2322. doi: 10.1109/TMI.2014.2337321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Barnett AH, Magland JF, Klinteberg L af. A parallel non-uniform fast Fourier transform library based on an “exponential of semicircle” kernel. arXiv. Preprint posted online 2018. doi: 10.48550/ARXIV.1808.06736 [DOI] [Google Scholar]
  • 47.Barnett AH. Aliasing error of the exp$(β\sqrt{1-z^2})$ kernel in the nonuniform fast Fourier transform. arXiv. Preprint posted online 2020. doi: 10.48550/ARXIV.2001.09405 [DOI] [Google Scholar]
  • 48.Assländer J, Cloos MA, Knoll F, Sodickson DK, Hennig J, Lattanzi R. Low rank alternating direction method of multipliers reconstruction for MR fingerprinting. Magn Reson Med. 2018;79(1):83–96. doi: 10.1002/mrm.26639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Golbabaee M, Pirkl CM, Menzel MI, Buonincontri G, Gómez PA. Deep MR Fingerprinting with total-variation and low-rank subspace priors. arXiv. Preprint posted online February 26, 2019:arXiv:1902.10205. doi: 10.48550/arXiv.1902.10205 [DOI] [Google Scholar]
  • 50.Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM. The NMR phased array. Magnetic Resonance in Med. 1990;16(2):192–225. doi: 10.1002/mrm.1910160203 [DOI] [PubMed] [Google Scholar]
  • 51.Bydder M, Ghodrati V, Gao Y, Robson MD, Yang Y, Hu P. Constraints in estimating the proton density fat fraction. Magnetic Resonance Imaging. 2020;66:1–8. doi: 10.1016/j.mri.2019.11.009 [DOI] [PubMed] [Google Scholar]
  • 52.McGivney DF, Pierre E, Ma D, et al. SVD Compression for Magnetic Resonance Fingerprinting in the Time Domain. IEEE Transactions on Medical Imaging. 2014;33(12):2311–2322. doi: 10.1109/TMI.2014.2337321 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hamilton G, Smith DL, Bydder M, Nayak KS, Hu HH. MR properties of brown and white adipose tissues. Magnetic Resonance Imaging. 2011;34(2):468–473. doi: 10.1002/jmri.22623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Peterson P, Trinh L, Månsson S. Quantitative1 H MRI and MRS of fatty acid composition. Magnetic Resonance in Med. 2021;85(1):49–67. doi: 10.1002/mrm.28471 [DOI] [PubMed] [Google Scholar]
  • 55.Ren J, Dimitrov I, Sherry AD, Malloy CR. Composition of adipose tissue and marrow fat in humans by 1H NMR at 7 Tesla. Journal of Lipid Research. 2008;49(9):2055–2062. doi: 10.1194/jlr.D800010-JLR200 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Strobel K, Van Den Hoff J, Pietzsch J. Localized proton magnetic resonance spectroscopy of lipids in adipose tissue at high spatial resolution in mice in vivo. Journal of Lipid Research. 2008;49(2):473–480. doi: 10.1194/jlr.D700024-JLR200 [DOI] [PubMed] [Google Scholar]
  • 57.Peterson P, Månsson S. Simultaneous quantification of fat content and fatty acid composition using MR imaging. Magnetic Resonance in Med. 2013;69(3):688–697. doi: 10.1002/mrm.24297 [DOI] [PubMed] [Google Scholar]
  • 58.Lang TA, Altman DG. Basic statistical reporting for articles published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or the SAMPL Guidelines. International Journal of Nursing Studies. 2015;52(1):5–9. doi: 10.1016/j.ijnurstu.2014.09.006 [DOI] [PubMed] [Google Scholar]
  • 59.Pearson K Note on Regression and Inheritance in the Case of Two Parents. Proceedings of the Royal Society of London Series I. 1895;58:240–242. [Google Scholar]
  • 60.Horn RA, Johnson CR. Topics in Matrix Analysis. 1st ed. Cambridge University Press; 1991. doi: 10.1017/CBO9780511840371 [DOI] [Google Scholar]
  • 61.Altman DG, Bland JM. Measurement in Medicine: The Analysis of Method Comparison Studies. The Statistician. 1983;32(3):307. doi: 10.2307/2987937 [DOI] [Google Scholar]
  • 62.Leporq B, Lambert SA, Ronot M, Vilgrain V, Van Beers BE. Quantification of the triglyceride fatty acid composition with 3.0 T MRI. NMR in Biomedicine. 2014;27(10):1211–1221. doi: 10.1002/nbm.3175 [DOI] [PubMed] [Google Scholar]
  • 63.Liao J, Saito N, Ozonoff A, Jara H, Steinberg M, Sakai O. Quantitative MRI analysis of salivary glands in sickle cell disease. Dentomaxillofac Radiol. 2012;41(8):630–636. doi: 10.1259/dmfr/31672000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Chikui T, Yamashita Y, Kise Y, Saito T, Okamura K, Yoshiura K. Estimation of proton density fat fraction of the salivary gland. The British Journal of Radiology. 2018;91(1085):20170671. doi: 10.1259/bjr.20170671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Lee A, Choi YJ, Jeon KJ, Han SS, Lee C. Development and accuracy validation of a fat fraction imaging biomarker for sialadenitis in the parotid gland. BMC Oral Health. 2023;23(1):347. doi: 10.1186/s12903-023-03024-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Lee A, Choi YJ, Jeon KJ, Han SS, Lee C. Impact of physiological parameters on the parotid gland fat fraction in a normal population. Sci Rep. 2023;13(1):990. doi: 10.1038/s41598-023-28193-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Chu C, Zhou N, Zhang H, et al. Added Value of Parotid R2* Values for Evaluation of Sjögren Syndrome: A Preliminary Study. J Comput Assist Tomogr. 2017;41(4):547–552. doi: 10.1097/RCT.0000000000000554 [DOI] [PubMed] [Google Scholar]
  • 68.Haskell MW, Nielsen JF, Noll DC. Off-resonance artifact correction for magnetic resonance imaging: a review. NMR Biomed. 2023;36(5):e4867. doi: 10.1002/nbm.4867 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Cui L, McWalter EJ, Moran G, Venugopal N. Design and development of a novel flexible ultra-short echo time (FUSE) sequence. Magnetic Resonance in Medicine. 2023;90(5):1905–1918. doi: 10.1002/mrm.29784 [DOI] [PubMed] [Google Scholar]
  • 70.Dikaios N, Protonotarios NE, Fokas AS, Kastis GA. Quantification of T1, T2 relaxation times from Magnetic Resonance Fingerprinting radially undersampled data using analytical transformations. Magnetic Resonance Imaging. 2021;80:81–89. doi: 10.1016/j.mri.2021.04.013 [DOI] [PubMed] [Google Scholar]
  • 71.Adjeiwaah M, Bylund M, Lundman JA, et al. Dosimetric Impact of MRI Distortions: A Study on Head and Neck Cancers. International Journal of Radiation Oncology*Biology*Physics. 2019;103(4):994–1003. doi: 10.1016/j.ijrobp.2018.11.037 [DOI] [PubMed] [Google Scholar]
  • 72.Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1–100 MHz: Dependence on tissue type, NMR frequency, temperature, species, excision, and age. Medical Physics. 1984;11(4):425–448. doi: 10.1118/1.595535 [DOI] [PubMed] [Google Scholar]
  • 73.Hernando D, Liang Z, Kellman P. Chemical shift–based water/fat separation: A comparison of signal models. Magnetic Resonance in Med. 2010;64(3):811–822. doi: 10.1002/mrm.22455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Chebrolu VV, Hines CDG, Yu H, et al. Independent estimation of T *2 for water and fat for improved accuracy of fat quantification. Magn Reson Med. 2010;63(4):849–857. doi: 10.1002/mrm.22300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.In Den Kleef JJE, Cuppen JJM. RLSQ: T1 , T2 , and ρ calculations, combining ratios and least squares. Magnetic Resonance in Med. 1987;5(6):513–524. doi: 10.1002/mrm.1910050602 [DOI] [PubMed] [Google Scholar]
  • 76.Havla L, Basha T, Rayatzadeh H, et al. Improved fat water separation with water selective inversion pulse for inversion recovery imaging in cardiac MRI. Magnetic Resonance Imaging. 2013;37(2):484–490. doi: 10.1002/jmri.23779 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Foo TK, Sawyer AM, Faulkner WH, Mills DG. Inversion in the steady state: contrast optimization and reduced imaging time with fast three-dimensional inversion-recovery-prepared GRE pulse sequences. Radiology. 1994;191(1):85–90. doi: 10.1148/radiology.191.1.8134602 [DOI] [PubMed] [Google Scholar]
  • 78.Kaldoudi E, Williams SCR, Barker GJ, Tofts PS. A chemical shift selective inversion recovery sequence for fat-suppressed MRI: Theory and experimental validation. Magnetic Resonance Imaging. 1993;11(3):341–355. doi: 10.1016/0730-725X(93)90067-N [DOI] [PubMed] [Google Scholar]
  • 79.Daudé P, Roussel T, Troalen T, et al. Comparative review of algorithms and methods for chemical-shift-encoded quantitative fat-water imaging. Magnetic Resonance in Medicine. 2024;91(2):741–759. doi: 10.1002/mrm.29860 [DOI] [PubMed] [Google Scholar]
  • 80.Glide-Hurst CK, Paulson ES, McGee K, et al. Task group 284 report: magnetic resonance imaging simulation in radiotherapy: considerations for clinical implementation, optimization, and quality assurance. Medical Physics. 2021;48(7):e636–e670. doi: 10.1002/mp.14695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Shih SF, Wu HH. Free-breathing MRI techniques for fat and R2* quantification in the liver. Magn Reson Mater Phy. 2024;37(4):583–602. doi: 10.1007/s10334-024-01187-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Song R, Song HK. Echo-spacing optimization for the simultaneous measurement of reversible (R2′) and irreversible (R2) transverse relaxation rates. Magnetic Resonance Imaging. 2007;25(1):63–68. doi: 10.1016/j.mri.2006.09.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM. Principles, Techniques, and Applications of T2*-based MR Imaging and Its Special Applications. RadioGraphics. 2009;29(5):1433–1449. doi: 10.1148/rg.295095034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Jaubert O, Arrieta C, Cruz G, et al. Multi-parametric liver tissue characterization using MR fingerprinting: Simultaneous T1 , T2 , T2 *, and fat fraction mapping. Magnetic Resonance in Med. 2020;84(5):2625–2635. doi: 10.1002/mrm.28311 [DOI] [PubMed] [Google Scholar]
  • 85.Fischler MA, Bolles RC. Random sample consensus: a paradigm for model fitting with applications to image analysis and automated cartography. Commun ACM. 1981;24(6):381–395. doi: 10.1145/358669.358692 [DOI] [Google Scholar]
  • 86.Zhao B, Haldar JP, Liao C, et al. Optimal Experiment Design for Magnetic Resonance Fingerprinting: Cramér-Rao Bound Meets Spin Dynamics. IEEE Trans Med Imaging. 2019;38(3):844–861. doi: 10.1109/TMI.2018.2873704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Heesterbeek DGJ, Koolstra K, van Osch MJP, van Gijzen MB, Vos FM, Nagtegaal MA. Mitigating undersampling errors in MR fingerprinting by sequence optimization. Magnetic Resonance in Medicine. 2023;89(5):2076–2087. doi: 10.1002/mrm.29554 [DOI] [PubMed] [Google Scholar]
  • 88.Slioussarenko C, Baudin PY, Marty B. A steady-state MR fingerprinting sequence optimization framework applied to the fast 3D quantification of fat fraction and water T1 in the thigh muscles. Magnetic Resonance in Medicine. 2025;93(6):2623–2639. doi: 10.1002/mrm.30490 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Chen Y, Jiang Y, Pahwa S, et al. MR Fingerprinting for Rapid Quantitative Abdominal Imaging. Radiology. 2016;279(1):278–286. doi: 10.1148/radiol.2016152037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Ma D, Jiang Y, Chen Y, et al. Fast 3D Magnetic Resonance Fingerprinting (MRF) For a Whole Brain Coverage. Magn Reson Med. 2018;79(4):2190–2197. doi: 10.1002/mrm.26886 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Ma D, Jones SE, Deshmane A, et al. Development of high-resolution 3D MR fingerprinting for detection and characterization of epileptic lesions. J Magn Reson Imaging. 2019;49(5):1333–1346. doi: 10.1002/jmri.26319 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Chen Y, Fang Z, Hung SC, Chang WT, Shen D, Lin W. High-resolution 3D MR Fingerprinting using parallel imaging and deep learning. NeuroImage. 2020;206:116329. doi: 10.1016/j.neuroimage.2019.116329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Chaudhary S, Lane EG, Levy A, et al. Estimation of fatty acid composition in mammary adipose tissue using deep neural network with unsupervised training. Magnetic Resonance in Med. 2025;93(5):2163–2175. doi: 10.1002/mrm.30401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Cheung SM, Chan KS, Zhou W, et al. Spatial heterogeneity of peri-tumoural lipid composition in postmenopausal patients with oestrogen receptor positive breast cancer. Sci Rep. 2024;14(1):4699. doi: 10.1038/s41598-024-55458-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Lewin AA, Storey P, Moccaldi M, Moy L, Gene Kim S. Fatty acid composition in mammary adipose tissue measured by Gradient-echo Spectroscopic MRI and its association with breast cancers. European Journal of Radiology. 2019;116:205–211. doi: 10.1016/j.ejrad.2019.04.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Schneider M, Janas G, Lugauer F, et al. Accurate fatty acid composition estimation of adipose tissue in the abdomen based on bipolar multi-echo MRI. Magnetic Resonance in Med. 2019;81(4):2330–2346. doi: 10.1002/mrm.27557 [DOI] [PubMed] [Google Scholar]
  • 97.Leporq B, Lambert SA, Ronot M, Vilgrain V, Van Beers BE. Quantification of the triglyceride fatty acid composition with 3.0 T MRI. NMR in Biomedicine. 2014;27(10):1211–1221. doi: 10.1002/nbm.3175 [DOI] [PubMed] [Google Scholar]
  • 98.Leporq B, Lambert SA, Ronot M, Vilgrain V, Van Beers BE. Simultaneous MR quantification of hepatic fat content, fatty acid composition, transverse relaxation time and magnetic susceptibility for the diagnosis of non-alcoholic steatohepatitis. NMR in Biomedicine. 2017;30(10):e3766. doi: 10.1002/nbm.3766 [DOI] [PubMed] [Google Scholar]
  • 99.Bresticker JE, Pavelec CM, Echols JT, Patel AR, Wolf MJ, Epstein FH. Preclinical MRI of proinflammatory epicardial adipose tissue: Accelerated methods for simultaneous fatty acid composition and relaxation parameter mapping with relationships to tissue biomarkers. Journal of Cardiovascular Magnetic Resonance Published online August 2025:101947. doi: 10.1016/j.jocmr.2025.101947 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Echols JT, Wang S, Patel AR, Hogwood AC, Abbate A, Epstein FH. Fatty acid composition MRI of epicardial adipose tissue: Methods and detection of proinflammatory biomarkers in ST-segment elevation myocardial infarction patients. Magnetic Resonance in Med. 2025;93(2):519–535. doi: 10.1002/mrm.30285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Shah SA, Echols JT, Sun C, Wolf MJ, Epstein FH. Accelerated fatty acid composition MRI of epicardial adipose tissue: Development and application to eplerenone treatment in a mouse model of obesity-induced coronary microvascular disease. Magnetic Resonance in Med. 2022;88(4):1734–1747. doi: 10.1002/mrm.29348 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Emin S, Oei EHG, Englund M, Peterson P. Imaging-based assessment of fatty acid composition in human bone marrow adipose tissue at 7 T: Method comparison and in vivo feasibility. Magnetic Resonance in Med. 2023;90(1):240–249. doi: 10.1002/mrm.29623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Trinh L, Peterson P, Leander P, Brorson H, Månsson S. In vivo comparison of MRI-based and MRS-based quantification of adipose tissue fatty acid composition against gas chromatography. Magnetic Resonance in Med. 2020;84(5):2484–2494. doi: 10.1002/mrm.28300 [DOI] [PubMed] [Google Scholar]
  • 104.Martel D, Leporq B, Saxena A, et al. 3T chemical shift-encoded MRI: Detection of altered proximal femur marrow adipose tissue composition in glucocorticoid users and validation with magnetic resonance spectroscopy. Magnetic Resonance Imaging. 2019;50(2):490–496. doi: 10.1002/jmri.26586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Vande Berg BC, Lecouvet FE, Galant C, Maldague BE, Malghem J. Normal Variants and Frequent Marrow Alterations that Simulate Bone Marrow Lesions at MR Imaging. Radiologic Clinics of North America. 2005;43(4):761–770. doi: 10.1016/j.rcl.2005.01.007 [DOI] [PubMed] [Google Scholar]
  • 106.Corbeau A, Kuipers SC, De Boer SM, et al. Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review. Radiotherapy and Oncology. 2021;164:128–137. doi: 10.1016/j.radonc.2021.09.009 [DOI] [PubMed] [Google Scholar]
  • 107.MacManus MP, Prins E, Xie J, et al. Dose-Response Relationships Between Radiation Exposure, Bone Marrow Function as Measured by 18F-Fluorothymidine Positron Emission Tomography, and Lymphocyte Counts During Chemoradiation for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 2025;121(2):375–387. doi: 10.1016/j.ijrobp.2024.08.035 [DOI] [PubMed] [Google Scholar]
  • 108.McCullum L, Shin J, Xing S, et al. Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations. International Journal of Radiation Oncology*Biology*Physics. 2023;116(5):1226–1233. doi: 10.1016/j.ijrobp.2023.01.054 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Shin J, Xing S, McCullum L, et al. HEDOS—a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations. Phys Med Biol. 2021;66(16):164001. doi: 10.1088/1361-6560/ac16ea [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Littlejohns TJ, Holliday J, Gibson LM, et al. The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions. Nat Commun. 2020;11(1):2624. doi: 10.1038/s41467-020-15948-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Thanaj M, Basty N, Whitcher B, Bell JD, Thomas EL. M RI assessment of adipose tissue fatty acid composition in the UK Biobank and its association with diet and disease. Obesity. 2024;32(9):1699–1708. doi: 10.1002/oby.24108 [DOI] [PubMed] [Google Scholar]
  • 112.Honecker J, Prokopchuk O, Seeliger C, et al. Feasibility of omega-3 fatty acid fraction mapping using chemical shift encoding-based imaging at 3 T. NMR in Biomedicine. 2024;37(10):e5181. doi: 10.1002/nbm.5181 [DOI] [PubMed] [Google Scholar]
  • 113.Simopoulos A Omega-3 fatty acids in health and disease and in growth and development. The American Journal of Clinical Nutrition. 1991;54(3):438–463. doi: 10.1093/ajcn/54.3.438 [DOI] [PubMed] [Google Scholar]
  • 114.De Aguiar Pastore Silva J, Emilia De Souza Fabre M, Waitzberg DL. Omega-3 supplements for patients in chemotherapy and/or radiotherapy: A systematic review. Clinical Nutrition. 2015;34(3):359–366. doi: 10.1016/j.clnu.2014.11.005 [DOI] [PubMed] [Google Scholar]
  • 115.Wei L, Wu Z, Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids-an update. Cancer Letters. 2022;526:193–204. doi: 10.1016/j.canlet.2021.11.023 [DOI] [PubMed] [Google Scholar]
  • 116.Skorpil M, Rydén H, Wejde J, Lidbrink E, Brosjö O, Berglund J. The effect of radiotherapy on fat content and fatty acids in myxoid liposarcomas quantified by MRI. Magnetic Resonance Imaging. 2017;43:37–41. doi: 10.1016/j.mri.2017.07.005 [DOI] [PubMed] [Google Scholar]
  • 117.Morgan MA, Lawrence TS. Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways. Clinical Cancer Research. 2015;21(13):2898–2904. doi: 10.1158/1078-0432.CCR-13-3229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Wang K, Zha Y, Lei H, Xu X. MRI Study on the Changes of Bone Marrow Microvascular Permeability and Fat Content after Total-Body X-Ray Irradiation. Radiation Research. 2018;189(2):205–212. doi: 10.1667/RR14865.1 [DOI] [PubMed] [Google Scholar]
  • 119.Delikatny EJ, Chawla S, Leung D, Poptani H. MR-visible lipids and the tumor microenvironment. NMR in Biomedicine. 2011;24(6):592–611. doi: 10.1002/nbm.1661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Arlauckas SP, Browning EA, Poptani H, Delikatny EJ. Imaging of cancer lipid metabolism in response to therapy. NMR in Biomedicine. 2019;32(10):e4070. doi: 10.1002/nbm.4070 [DOI] [PubMed] [Google Scholar]
  • 121.Vasseur S, Guillaumond F. Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance. Oncogenesis. 2022;11(1):46. doi: 10.1038/s41389-022-00420-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Lee S, Poptani H, Pickup S, et al. Early detection of radiation therapy response in non-Hodgkin’s lymphoma xenografts by in vivo1 H magnetic resonance spectroscopy and imaging. NMR in Biomedicine. 2010;23(6):624–632. doi: 10.1002/nbm.1505 [DOI] [PubMed] [Google Scholar]
  • 123.Hakumäki JM, Poptani H, Sandmair AM, Ylä-Herttuala S, Kauppinen RA. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis. Nat Med. 1999;5(11):1323–1327. doi: 10.1038/15279 [DOI] [PubMed] [Google Scholar]
  • 124.Kuesel AC, Sutherland GR, Halliday W, Smith ICP. 1 H MRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR in Biomedicine. 1994;7(3):149–155. doi: 10.1002/nbm.1940070308 [DOI] [PubMed] [Google Scholar]
  • 125.Doblas S, He T, Saunders D, et al. In vivo characterization of several rodent glioma models by1 H MRS. NMR in Biomedicine. 2012;25(4):685–694. doi: 10.1002/nbm.1785 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.He Q, Shkarin P, Hooley RJ, Lannin DR, Weinreb JC, Bossuyt VIJ. In vivo MR spectroscopic imaging of polyunsaturated fatty acids (PUFA) in healthy and cancerous breast tissues by selective multiple-quantum coherence transfer (Sel-MQC): A preliminary study. Magnetic Resonance in Med. 2007;58(6):1079–1085. doi: 10.1002/mrm.21335 [DOI] [PubMed] [Google Scholar]
  • 127.Delgado-Goñi T, Julià-Sapé M, Candiota AP, Pumarola M, Arús C. Molecular imaging coupled to pattern recognition distinguishes response to temozolomide in preclinical glioblastoma. NMR in Biomedicine. 2014;27(11):1333–1345. doi: 10.1002/nbm.3194 [DOI] [PubMed] [Google Scholar]
  • 128.MacEwan IJ, Glembotski NE, D’Lima D, et al. Proton density water fraction as a biomarker of bone marrow cellularity: Validation in ex vivo spine specimens. Magnetic Resonance Imaging. 2014;32(9):1097–1101. doi: 10.1016/j.mri.2014.03.005 [DOI] [PubMed] [Google Scholar]
  • 129.Peterson DE, Koyfman SA, Yarom N, et al. Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline. JCO. 2024;42(16):1975–1996. doi: 10.1200/JCO.23.02750 [DOI] [PubMed] [Google Scholar]
  • 130.Yu VY, Otazo R, Wu C, et al. Quantitative longitudinal mapping of radiation-treated prostate cancer using MR fingerprinting with radial acquisition and subspace reconstruction. Magn Reson Imaging. 2023;101:25–34. doi: 10.1016/j.mri.2023.03.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Rafat M, Ali R, Graves EE. Imaging radiation response in tumor and normal tissue. Am J Nucl Med Mol Imaging. 2015;5(4):317–332. [PMC free article] [PubMed] [Google Scholar]
  • 132.Carmona R, Pritz J, Bydder M, et al. Fat Composition Changes in Bone Marrow During Chemotherapy and Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2014;90(1):155–163. doi: 10.1016/j.ijrobp.2014.05.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Skorpil M, Rydén H, Berglund J, Brynolfsson P, Brosjö O, Tsagozis P. Soft-tissue fat tumours: differentiating malignant from benign using proton density fat fraction quantification MRI. Clinical Radiology. 2019;74(7):534–538. doi: 10.1016/j.crad.2019.01.011 [DOI] [PubMed] [Google Scholar]
  • 134.Skorpil M, Rydén H, Wejde J, Lidbrink E, Brosjö O, Berglund J. The effect of radiotherapy on fat content and fatty acids in myxoid liposarcomas quantified by MRI. Magnetic Resonance Imaging. 2017;43:37–41. doi: 10.1016/j.mri.2017.07.005 [DOI] [PubMed] [Google Scholar]
  • 135.Tang R, Tang G, Hua T, Tu Y, Ji R, Zhu J. mDIXON-Quant technique diagnostic accuracy for assessing bone mineral density in male adult population. BMC Musculoskelet Disord. 2023;24(1):125. doi: 10.1186/s12891-023-06225-z [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1

Figure S-1. The first 500 ms of the sequence showing the inversion pulse and increasing flip angle amplitude in the RF amplitude line. Not shown is a manual delay of 12 seconds that was added before the inversion pulse to ensure equilibrium conditions are met following the prescan procedures.

Figure S4

Figure S-4. A visualization of the complete image acquisition to reconstruction workflow where green = input data, blue = data processing steps, yellow = decision step, orange = intermediate data, and red = final output data.

Figure S5

Figure S-5. A comparison of the quantitative T1, T2, R2*, and PDFF maps generated from the proposed MRF sequence (top) with the MDME for T1 / T2 and mDIXON-Quant for R2* / PDFF reference sequences for the same healthy volunteer at the same window / level settings.

Figure S2

Figure S-2. A single repetition of the bipolar gradient echo radial readout. Shown is the RF pulse centered on the slice-select gradient followed by a rephasing gradient before the start of the readout. Immediately following this, a dephasing gradient is played out in the frequency encoding direction followed by 9 bipolar gradient echo readouts without ramp sampling as seen in the acquisition line. Another gradient is utilized at the end of the bipolar gradient readout to return to the center of k-space while an 8-cycle gradient crusher is applied in the slice-select line.

Figure S3

Figure S-3. A sample flip angle train that was generated for the acquisitions in this study. Note that only the first 2048 dynamics were used.

Figure S6

Figure S-6. Concordance plots of the quantitative T1 (top left), T2 (top right), R2* (bottom left), and PDFF (bottom right) values from the proposed MRF sequence compared to the phantom nominal reference values (dashed black line, CaliberMRI NIST/ISMRM Model 130 for T1 and T2, Calimetrix Model 725 for R2* and PDFF, and additional in-house phantom for PDFF). For each series of data, a linear line of best fit (solid black line) was computed along with its 95% confidence intervals (dashed red lines).

Figure S7

Figure S-7. Bland-Altman plots of the quantitative T1 (top left), T2 (top right), R2* (bottom left), and PDFF (bottom right) values from the proposed MRF sequence compared to the reference values (CaliberMRI NIST/ISMRM Model 130 and MDME for T1 and T2, Calimetrix Model 725 and mDIXON-Quant for R2* and PDFF with additional in-house phantom for PDFF). For each series of data, the mean (solid line) was computed along with its 95% limits of agreement (dashed lines).

Data Availability Statement

All relevant anonymized imaging data necessary for figure reproduction is available at the following FigShare DOI: 10.6084/m9.figshare.30779273. The MRF reconstruction code is freely available at: https://github.com/Lucas-Mc/MRF-MRL.

RESOURCES